[1. Ganova-Iolovska M, Kalinov K, Geraedts M. Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study. BMC Health Serv Res 2009;9:15. doi: 10.1186/1472-6963-9-15.10.1186/1472-6963-9-15265444319171057]Search in Google Scholar
[2. Ministry of Health - National Centre of Public Health and Analyses. Hospitalized Patients (discharged and deceased) in Hospitals of ICD-10 [displayed 22 July 2014]. Available at http://www.webcitation.org/6RGLCGLuy]Search in Google Scholar
[3. Ministry of Health - National Statistical Institute. Здравеопазване 2013 [Healthcare 2013, in Bulgarian] [displayed 22 July 2014]. Available at http://www.webcitation.org/6RVn1cCWV]Search in Google Scholar
[4. Marginean I, Precupetu I, Tzanov V, Preoteasa AM, Voicu B. First European Quality of Life Survey: Quality of life in Bulgaria and Romania. Luxembourg: Office for Official Publications of the European Communities; 2006 [displayed 22 July 2014]. Available at http://www.eurofound.europa.eu/pubdocs/2006/67/en/1/ef0667en.pdf]Search in Google Scholar
[5. Dimova A, Rohova M, Moutafova E, Atanasova E, Koeva S, Panteli D, van Ginneken E. Bulgaria health system review. Health Syst Transit 2012;14:1-186. PMID: 22894828]Search in Google Scholar
[6. Andreeva VA, Sakuma KL. Adapting smoking cessation programming to the Bulgarian context. Eval Health Prof 2008;31:290-6. doi: 10.1177/016327870832014910.1177/016327870832014918559883]Search in Google Scholar
[7. Stefanov TS, Temelkova-Kurktschiev TS. The metabolic syndrome in Bulgaria. Folia Med (Plovdiv) 2011;53:5-14. doi: 10.2478/v10153-011-0061-210.2478/v10153-011-0061-222708468]Search in Google Scholar
[8. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S; INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-40. doi: 10.1093/eurheartj/ehn01810.1093/eurheartj/ehn01818334475]Search in Google Scholar
[9. Babisch W. Updated exposure-response relationship between road traffic noise and coronary heart diseases: A metaanalysis. Noise Health 2014;16:1-9. doi: 10.4103/1463-1741.127847.10.4103/1463-1741.12784724583674]Search in Google Scholar
[10. Goines L, Hagler L. Noise pollution: a modem plague. South Med J 2007;100:287-94. PMID: 1739673310.1097/SMJ.0b013e3180318be517396733]Search in Google Scholar
[11. Andersson K, Lindvall T. Health Effects of Community Noise; Evaluation of the Nordic Project on “The Health Effects of Community Noise”. Copenhagen: Nordic Council of Ministers; 1988.]Search in Google Scholar
[12. Spreng M. Central nervous system activation by noise. Noise Health 2000;2:49-58. PMID: 12689471]Search in Google Scholar
[13. Ising H, Kruppa B. Health effects caused by noise: evidence in the literature from the past 25 years. Noise Health 2004;6:5-13. PMID: 15070524]Search in Google Scholar
[14. Westman JC, Walters JR. Noise and stress: a comprehensive approach. Environ Health Perspect 1981;41:291-309. PMID: 733324310.1289/ehp.814129115688507333243]Search in Google Scholar
[15. WHO Regional Office for Europe. Burden of Disease from Environmental Noise. Quantification of Healthy Life Years Lost in Europe. Copenhagen: WHO Regional Office for Europe; 2011.]Search in Google Scholar
[16. Noise Observation and Information Service for Europe (NOISE). Copenhagen, European Environment Agency [displayed 22 July 2014G. Available at http://noise.eionet.europa.eu/]Search in Google Scholar
[17. Berglund B, Lindvall T, Schwella DH, editors. Guidelines for Community Noise. Geneva: World Health Organization; 1999 [displayed 22 July 2014]. Available at http://www.who.int/docstore/peh/noise/noiseindex.html]Search in Google Scholar
[18. Ricardo-AEA. Update of the Handbook on External Costs of Transport - Report for the European Commission: DG MOVE; 2014 [displayed 22 July 2014]. Available at http://ec.europa.eu/transport/themes/sustainable/studies/doc/2014-handbook-external-costs-transport.pdf]Search in Google Scholar
[19. Harding AH, Frost GA, Tan E, Tsuchiya A, Mason HM. The cost of hypertension-related ill-health attributable to environmental noise. Noise Health 2013;15:437-45. doi: 10.4103/1463-1741.12125310.4103/1463-1741.12125324231422]Search in Google Scholar
[20. Paunovic K, Belojević G. Burden of myocardial infarction attributable to road-traffic noise: A pilot study in Belgrade. Noise Health 2014;16:374-9. doi: 10.4103/1463-1741.14441510.4103/1463-1741.14441525387533]Search in Google Scholar
[21. Laaksonen M. Population Attributable Fraction (PAF) in Epidemiologic Follow-up Studies [PhD thesis]. Helsinki: National Institute for Health and Welfare, Finland; 2010 [displayed 22 July 2014]. Available at http://www.webcitation.org/6RGXvijCr]Search in Google Scholar
[22. Kirkdale R, Krell J, O’Hanlon Brown C, Tuthill M, Waxman J. The cost of a QALY. QJM 2010;103:715-20. doi: 10.1093/ qjmed/hcq08110.1093/qjmed/hcq08120519275]Search in Google Scholar
[23. Mathers CD, Bernard C, Iburg KM, Inoue M, Fat DM, Shibuya K, Stein C, Tomijima N, Xu H. Global Burden of Disease in 2002: Data sources, methods and results. World Health Organisation; 2003 (Revised February 2004) [displayed 22 July 2014]. Available at http://www.who.int/healthinfo/paper54.pdf]Search in Google Scholar
[24. van Domburg RT, Sonnenschein K, Nieuwlaat R, Kamp O, Storm CJ, Bax JJ, Simoons ML. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 2005;46:15-20. doi: 10.1016/j. jacc.2005.03.047]Search in Google Scholar
[25. Annemans L, Lamotte M, Clarys P, Van den Abeele E. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Eur J Cardiovasc Prev Rehabil 2007;14:815-24. doi: 10.1097/HJR.0b013e3282ef514f10.1097/HJR.0b013e3282ef514f18043305]Search in Google Scholar
[26. Riegelman R. Non-communicable diseases. In: Public Health 101: Healthy People - Healthy Populations. London: Jones and Bartlett Publishers; 2010. p. 94.]Search in Google Scholar
[27. European Commission, EUROSTAT. GDP and beyond, Measuring quality of life in the EU; 2014 [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-19032014-CP/EN/3-19032014-CP-EN.PDF]Search in Google Scholar
[28. European Commission, EUROSTAT. Annual national accounts (nama) [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY_SDDS/EN/nama_esms.htm]Search in Google Scholar
[29. Ministry of Health. [National Invasive Cardiology Registry, in Bulgarian]. [displayed 22 July 2014]. Available at http:// www.mh.government.bg/]Search in Google Scholar
[30. den Boer LC, Schroten A. Traffic noise reduction in Europe. Report. CE Delft; 2007 [displayed 22 July 2014]. Available at http://www.transportenvironment.org/sites/te/files/media/2008-02_traffic_noise_ce_delft_report.pdf]Search in Google Scholar
[31. Poirazis H. Double Skin Façades: A Literature Review. A report of IEA SHC Task 34 ECBCS Annex 43; 2006 [displayed 22 July 2014]. Available at http://www.ecbcs.org/docs/Annex_43_Task34-Double_Skin_Facades_A_Literature_Review.pdf]Search in Google Scholar
[32. Dzhambov AM, Dimitrova DD. Urban green spaces’ effectiveness as a psychological buffer for the negative health impact of noise pollution: A systematic review. Noise Health 2014;16:157-65. doi: 10.4103/1463-1741.134916.10.4103/1463-1741.13491624953881]Search in Google Scholar
[33. World Health Organization (WHO). Evaluation and Use of Epidemiological Evidence for Environmental Health Risk Assessment. Guideline document. Copenhagen: WHO Regional Office for Europe, 2000 [displayed 20 June 2014]. Available at http://www.euro.who.int/document/e68940.pdf]Search in Google Scholar
[34. De Smedt D, Kotseva K, De Bacquer D, Wood D, De Backer G, Dallongeville J, Seppo L, Pajak A, Reiner Z, Vanuzzo D, Georgiev B, Gotcheva N, Annemans L. Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. Eur Heart J 2012;33:2865-72. doi: 10.1093/eurheartj/ehs21010.1093/eurheartj/ehs21022843446]Search in Google Scholar
[35. Petrova G, Ivanova A, Czech M, Valov V, Wrona W, Niewada M, Savova A. Liraglutide vs. Exenatide in Combination with Metformin and/or Sulfonylurea Therapy in Type 2 Diabetes Mellitus Therapy in Bulgaria. A Modelling Study. Comptes rendus de l’Acade’mie bulgare des Sciences 2011;64:1507-14.]Search in Google Scholar
[36. Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006;21:402-8. doi: 10.1093/heapol/czl018 10.1093/heapol/czl01816877455]Search in Google Scholar